CONCORD logo

Concord Drugs Ltd

CONCORD·BSE·
80.80 +0.49 (+0.61%)
Market Cap103.71 Cr
PE Ratio269.33
Volume1,212
Day High - Low81.99 - 78.59
52W High-Low92.52 - 64.00
DocStoX Score
2.8/10
Poor
Fair Value
Sign in to see
ROE
2.52%
Weak
P/E
269.33x
Expensive
Debt / Equity
0.24
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day78.59
81.99
52W64.00
92.52
DocStoX take

Supported by momentum (6.3), but held back by valuation (0.0).

DocStoX score

Low confidence
2.8
/10
Poor
Quality
Weak
ROE 2.5%
Valuation
Expensive
P/E 200.0×
Growth
Flat
Revenue +8.9% 5Y CAGR
Risk
Moderate
D/E 0.24
Momentum
Firm
59% of 52-week range

At a glance

Market Cap
₹104 Cr
52W High / Low
₹93 / ₹64
Dividend Yield
0.00%
Promoter Holding
45.08%
EPS (TTM)
₹0.30
Book Value
₹36.82

Key highlights

  • Low leverage — D/E 0.24
  • Profitable in all of the last 5 years
  • Profit shrinking 20% a year
  • Valuation is weak (0.0/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Concord Drugs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.